Literature DB >> 16824682

Phosphorylation of neurogranin, protein kinase C, and Ca2+/calmodulin dependent protein kinase II in opioid tolerance and dependence.

Pradeep K Shukla1, Lei Tang, Zaijie Jim Wang.   

Abstract

Activation of Ca2+/calmodulin dependent protein kinase II (CaMKII) and protein kinase C (PKC) are hallmarks of opioid tolerance and dependence. It is not known if the actions of these two kinases are synchronized by a common mechanism in opioid tolerance and dependence. Neurogranin (Ng), through mechanisms such as phosphorylation, has been previously proposed to regulate the activities of these protein kinases. We examined the phosphorylation status of neurogranin in mice that were made tolerant to opioids by morphine (100 mg/kg, s.c.). Increase in phosphorylation of neurogranin was found both in brains and spinal cords of morphine-treated mice, as compared to the untreated baseline or saline-treated mice. The effect appeared to correlate with the changes in the activities of PKC and CaMKII, and with the development of opioid tolerance and dependence. We have found that neurogranin activity is regulated in opioid tolerance and dependence. Neurogranin may, therefore, provide a potential mechanism interacting with both CaMKII and PKC in opioid tolerance and dependence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824682     DOI: 10.1016/j.neulet.2006.06.013

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Involvement of protein kinase C in morphine tolerance at spinal levels of rats.

Authors:  Wu-Yang Jin; Long-Chuan Yu
Journal:  ACS Chem Neurosci       Date:  2009-10-05       Impact factor: 4.418

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 3.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

4.  Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5.

Authors:  A M Gregus; C N Inra; T P Giordano; A C S Costa; A M Rajadhyaksha; C E Inturrisi
Journal:  Neuroscience       Date:  2010-03-29       Impact factor: 3.590

5.  Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain.

Authors:  Neha Chauhan; Rajeev Taliyan; Pyare Lal Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-17       Impact factor: 3.000

6.  Mice lacking rhes show altered morphine analgesia, tolerance, and dependence.

Authors:  Franklin A Lee; Brandon A Baiamonte; Daniela Spano; Gerald J Lahoste; R Denis Soignier; Laura M Harrison
Journal:  Neurosci Lett       Date:  2010-12-14       Impact factor: 3.046

Review 7.  Rhes: a GTP-binding protein integral to striatal physiology and pathology.

Authors:  Laura M Harrison
Journal:  Cell Mol Neurobiol       Date:  2012-03-27       Impact factor: 5.046

8.  Neurogranin binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease.

Authors:  Andrew O Koob; Gideon M Shaked; Andreas Bender; Alejandro Bisquertt; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Res       Date:  2014-10-19       Impact factor: 3.252

9.  Prenatal thyroxine treatment disparately affects peripheral and amygdala thyroid hormone levels.

Authors:  Pradeep K Shukla; Laura J Sittig; Brian M Andrus; Daniel J Schaffer; Kanchi K Batra; Eva E Redei
Journal:  Psychoneuroendocrinology       Date:  2009-12-11       Impact factor: 4.905

10.  Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.

Authors:  Yan Chen; Cheng Yang; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.